Founders Fund VI Management

Latest statistics and disclosures from Founders Fund VI Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ROIV, CYTH, and represent 100.00% of Founders Fund VI Management's stock portfolio.
  • Added to shares of these 1 stock: CYTH.
  • Started 1 new stock position in CYTH.
  • Reduced shares in these 1 stock: Applied Molecular Trans.
  • Sold out of its position in Applied Molecular Trans.
  • Founders Fund VI Management was a net buyer of stock by $45k.
  • Founders Fund VI Management has $13M in assets under management (AUM), dropping by -3.47%.
  • Central Index Key (CIK): 0001853382

Tip: Access up to 7 years of quarterly data

Positions held by Founders Fund VI Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Founders Fund VI Management

Founders Fund VI Management holds 2 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Roivant Sciences SHS (ROIV) 98.6 $13M 1.1M 11.23
 View chart
Cyclo Therapeutics Com New (CYTH) 1.4 $175k NEW 110k 1.59
 View chart

Past Filings by Founders Fund VI Management

SEC 13F filings are viewable for Founders Fund VI Management going back to 2021